Genetic and molecular changes in ovarian cancer

Epithelial ovarian cancer represents the most lethal gynecological malignancy in the developed world, and can be divided into five main histological subtypes: high grade serous, endometrioid, clear cell, mucinous and low grade serous. These subtypes represent distinct disease entities, both clinical...

Full description

Bibliographic Details
Main Authors: Robert L Hollis, Charlie Gourley
Format: Article
Language:English
Published: China Anti-Cancer Association 2016-06-01
Series:Cancer Biology & Medicine
Subjects:
Online Access:http://www.cancerbiomed.org/index.php/cocr/article/view/929
id doaj-9224b816c88b4c53b1c8586c108c9327
record_format Article
spelling doaj-9224b816c88b4c53b1c8586c108c93272020-11-24T21:48:20ZengChina Anti-Cancer AssociationCancer Biology & Medicine2095-39412095-39412016-06-0113223624710.20892/j.issn.2095-3941.2016.00242016000024Genetic and molecular changes in ovarian cancerRobert L Hollis0Charlie Gourley1Edinburgh Cancer Research UK Centre, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, EH4 2XR, UKEdinburgh Cancer Research UK Centre, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, EH4 2XR, UKEpithelial ovarian cancer represents the most lethal gynecological malignancy in the developed world, and can be divided into five main histological subtypes: high grade serous, endometrioid, clear cell, mucinous and low grade serous. These subtypes represent distinct disease entities, both clinically and at the molecular level. Molecular analysis has revealed significant genetic heterogeneity in ovarian cancer, particularly within the high grade serous subtype. As such, this subtype has been the focus of much research effort to date, revealing molecular subgroups at both the genomic and transcriptomic level that have clinical implications. However, stratification of ovarian cancer patients based on the underlying biology of their disease remains in its infancy. Here, we summarize the molecular changes that characterize the five main ovarian cancer subtypes, highlight potential opportunities for targeted therapeutic intervention and outline priorities for future research.http://www.cancerbiomed.org/index.php/cocr/article/view/929Ovarian cancermolecular geneticshistological subtypesmolecular subgroupingovary
collection DOAJ
language English
format Article
sources DOAJ
author Robert L Hollis
Charlie Gourley
spellingShingle Robert L Hollis
Charlie Gourley
Genetic and molecular changes in ovarian cancer
Cancer Biology & Medicine
Ovarian cancer
molecular genetics
histological subtypes
molecular subgrouping
ovary
author_facet Robert L Hollis
Charlie Gourley
author_sort Robert L Hollis
title Genetic and molecular changes in ovarian cancer
title_short Genetic and molecular changes in ovarian cancer
title_full Genetic and molecular changes in ovarian cancer
title_fullStr Genetic and molecular changes in ovarian cancer
title_full_unstemmed Genetic and molecular changes in ovarian cancer
title_sort genetic and molecular changes in ovarian cancer
publisher China Anti-Cancer Association
series Cancer Biology & Medicine
issn 2095-3941
2095-3941
publishDate 2016-06-01
description Epithelial ovarian cancer represents the most lethal gynecological malignancy in the developed world, and can be divided into five main histological subtypes: high grade serous, endometrioid, clear cell, mucinous and low grade serous. These subtypes represent distinct disease entities, both clinically and at the molecular level. Molecular analysis has revealed significant genetic heterogeneity in ovarian cancer, particularly within the high grade serous subtype. As such, this subtype has been the focus of much research effort to date, revealing molecular subgroups at both the genomic and transcriptomic level that have clinical implications. However, stratification of ovarian cancer patients based on the underlying biology of their disease remains in its infancy. Here, we summarize the molecular changes that characterize the five main ovarian cancer subtypes, highlight potential opportunities for targeted therapeutic intervention and outline priorities for future research.
topic Ovarian cancer
molecular genetics
histological subtypes
molecular subgrouping
ovary
url http://www.cancerbiomed.org/index.php/cocr/article/view/929
work_keys_str_mv AT robertlhollis geneticandmolecularchangesinovariancancer
AT charliegourley geneticandmolecularchangesinovariancancer
_version_ 1725892805459443712